Brief: Oncozenge Initiates Toxicity Study And Announces Modification To Clinical Plan

Oncozenge AB

15/02/2022 07:09

Feb 15 (Reuters) - Oncozenge AB  ONCOZ.ST :
    * ONCOZENGE INITIATES TOXICITY STUDY AND ANNOUNCES
MODIFICATION TO
THE CLINICAL PLAN
    * RESPONSE FROM FDA REGARDING STUDY DESIGN , PATIENT
POPULATION
NOW EXPECTED AT END OF MARCH
    * TARGET TO HAVE TOPLINE DATA FROM EUROPEAN PHASE III STUDY
END OF
2023 REMAINS UNCHANGED

Source text for Eikon:  ID:nWkr71ZYwT 
Further company coverage:  ONCOZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))